These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38693102)

  • 1. Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease.
    Zhang C; Rehman M; Tian X; Pei SLC; Gu J; Bell TA; Dong K; Tham MS; Cai Y; Wei Z; Behrens F; Jetten AM; Zhao H; Lek M; Somlo S
    Nat Commun; 2024 May; 15(1):3698. PubMed ID: 38693102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
    Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
    J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilia and polycystic kidney disease.
    Ma M
    Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic kidney disease: novel insights into polycystin function.
    Luo L; Roy S; Li L; Ma M
    Trends Mol Med; 2023 Apr; 29(4):268-281. PubMed ID: 36805211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the co-chaperone DNAJB11 in polycystic kidney disease: Molecular mechanisms and cellular origin of cyst formation.
    Busch T; Neubauer B; Schmitt L; Cascante I; Knoblich L; Wegehaupt O; Schöler F; Tholen S; Hofherr A; Schell C; Schilling O; Westermann L; Köttgen M
    FASEB J; 2024 Nov; 38(21):e70162. PubMed ID: 39530576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
    Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
    Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
    Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
    Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus.
    Ha K; Nobuhara M; Wang Q; Walker RV; Qian F; Schartner C; Cao E; Delling M
    Elife; 2020 Nov; 9():. PubMed ID: 33164752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease.
    Viau A; Baaziz M; Aka A; Mazloum M; Nguyen C; Kuehn EW; Terzi F; Bienaimé F
    J Am Soc Nephrol; 2020 May; 31(5):1035-1049. PubMed ID: 32238474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystin-2-dependent transcriptome reveals early response of autosomal dominant polycystic kidney disease.
    Jung HJ; Dixon EE; Coleman R; Watnick T; Reiter JF; Outeda P; Cebotaru V; Woodward OM; Welling PA
    Physiol Genomics; 2023 Nov; 55(11):565-577. PubMed ID: 37720991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyst formation following disruption of intracellular calcium signaling.
    Kuo IY; DesRochers TM; Kimmerling EP; Nguyen L; Ehrlich BE; Kaplan DL
    Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14283-8. PubMed ID: 25228769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway.
    Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP
    Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilia-enriched oxysterol 7β,27-DHC is required for polycystin ion channel activation.
    Ha K; Mundt-Machado N; Bisignano P; Pinedo A; Raleigh DR; Loeb G; Reiter JF; Cao E; Delling M
    Nat Commun; 2024 Jul; 15(1):6468. PubMed ID: 39085216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular advances in autosomal dominant polycystic kidney disease.
    Gallagher AR; Germino GG; Somlo S
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):118-30. PubMed ID: 20219615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
    Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Suramin on Polycystic Kidney Disease in a Mouse Model of Polycystin-1 Deficiency.
    Chang MY; Hsu SH; Ma LY; Chou LF; Hung CC; Tian YC; Yang CW
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease.
    Leonhard WN; Song X; Kanhai AA; Iliuta IA; Bozovic A; Steinberg GR; Peters DJM; Pei Y
    EBioMedicine; 2019 Sep; 47():436-445. PubMed ID: 31473186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
    Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
    Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
    Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.